Anzag
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Anzag - overview
Location
Frankfurt, -, Germany
Primary Industry
Logistics & Distribution
About
Anzag is a pharmaceutical wholesaler that connects pharmacies with manufacturers, ensuring timely access to health products across Germany. Anzag specializes in pharmaceutical wholesale, facilitating the distribution of medications. Founded in Frankfurt, Germany, it has operated under various business strategies. The company was part of a significant deal in June 2012 when Alliance Boots GmbH acquired a 14.
1% stake. The CEO and Founder details are not specified, and the firm has conducted 2 deals, with the most recent deal occurring on June 26, 2012. Anzag operates as a crucial intermediary between pharmacies and pharmaceutical manufacturers, distributing around 130,000 medicinal and health-related products. The company ensures compliance with high standards and tailors its services to meet the specific needs of clients.
Key offerings include customized marketing solutions for pharmacies, enhancing their visibility amid competition, and ensuring efficient medication delivery throughout Germany. Anzag generated revenue of USD 11,191. 87 mn in the most recent year, 2023. The EBITDA for the same year was USD 196.
46 mn. Revenue is primarily derived from B2B transactions with pharmacies and manufacturers, focusing on direct sales agreements and marketing support. Anzag aims to expand its market reach and is evaluating new product launches designed to enhance its service offerings. The company plans to tap into additional geographic regions within Germany while potentially considering strategic moves into neighboring markets.
The recent funding, following the acquisition by Alliance Boots GmbH, will be instrumental in supporting these growth initiatives.
Current Investors
Walgreens Boots Alliance, Inc.
Primary Industry
Logistics & Distribution
Sub Industries
Drug Stores/Convenience Stores, Pharmaceuticals
Website
www.anzag.de
Company Stage
Add-on
Total Amount Raised
Subscriber access only
Anzag - timeline of key events
Anzag - financials
| Fiscal Year Ended | Aug 31, 2019 | Aug 31, 2020 | Oct 31, 2020 | Aug 31, 2021 | Aug 31, 2022 | Aug 31, 2023 | Aug 31, 2024 |
|---|---|---|---|---|---|---|---|
| Revenue (USD) | 4,120,077,000 | 4,329,734,000 | 759,697,000 | 7,993,238,000 | - | - | - |
| % Revenue Growth (YoY) | - | 5.1% | - | - | - | - | - |
| EBITDA (USD) | 16,782,000 | 9,696,000 | (1,609,000) | (12,025,000) | - | - | - |
| Operating Income (USD) | 7,454,000 | (2,909,000) | (2,991,000) | (29,253,000) | - | - | - |
| Operating Margin | 0.2% | (0.1%) | (0.4%) | (0.4%) | - | - | - |
| % EBITDA Margin | 0.4% | 0.2% | (0.2%) | (0.2%) | - | - | - |
| NET Income (USD) | 2,885,000 | 133,338,000 | (3,226,000) | (19,897,000) | - | - | - |
| % Net Margin | 0.1% | 3.1% | (0.4%) | (0.2%) | - | - | - |
Anzag - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Add-on | Completed | Anzag | - | ||||||||
| Add-on | Completed | Anzag | - |
Displaying 1 - 2 of 2
Anzag - employee data
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.